⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22721286 | 0.79 | — | — | |
| SCHEMBL10276 | 0.73 | — | — | |
| SCHEMBL4352473 | 0.62 | — | — | |
| SCHEMBL4351236 | 0.62 | — | — | |
| SCHEMBL1561327 | 0.62 | — | — | |
| SCHEMBL4354628 | 0.62 | — | — | |
| SCHEMBL1203 | 0.62 | — | — | |
| SCHEMBL1387786 | 0.61 | — | — | |
| SCHEMBL482331 | 0.61 | — | — | |
| SCHEMBL420893 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210107912-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. | 2021-04-15 | — | — | US | claimed |
| EP-3489232-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2019-05-29 | — | — | EP | claimed |
| US-20170174692-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2017-06-22 | — | — | US | claimed |
| EP-3129371-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| EP-3126352-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2017-02-08 | — | — | EP | claimed |
| WO-2015154039-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | claimed |
| WO-2015154022-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | claimed |
| CN-117015568-A | Composition, substrate with surface layer, and method for producing substrate with surface layer | ＡＧＣ株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-20230250052-A1 | SEPARATION METHOD | AGC Inc. (JP) | 2023-08-10 | — | — | US | disclosed |
| CN-116535950-A | Method for preserving fluorine-containing composition, container containing fluorine-containing composition, and method for producing container containing fluorine-containing composition | ＡＧＣ株式会社 | 2023-08-04 | — | — | CN | disclosed |
| CN-116535952-A | Method for preserving fluorine-containing composition, container containing fluorine-containing composition, and method for producing container containing fluorine-containing composition | ＡＧＣ株式会社 | 2023-08-04 | — | — | CN | disclosed |
| US-20230174446-A1 | METHOD FOR PRODUCING FLUORINATED ETHER COMPOUND | AGC Inc. (JP) | 2023-06-08 | — | — | US | disclosed |
| CN-116234854-A | Process for producing fluoroether compound | ＡＧＣ株式会社 | 2023-06-06 | — | — | CN | disclosed |
| US-7070838-B2 | Liquid crystalline compound, liquid crystal composition and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2006-07-04 | — | — | US | disclosed |
| US-20050007541-A1 | Liquid crystalline compound, liquid crystal composition and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-5961880-A | LIQUID-CRYSTAL DISPLAY ELEMENT | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1999-10-05 | — | — | US | disclosed |
| EP-0559860-B1 | HALOVINYL-DERIVATIVES | HOFFMANN LA ROCHE (CH) | 1996-02-14 | — | — | EP | disclosed |
| US-5364556-A | Halovinyl-derivatives | HOFFMANN-LA ROCHE INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0559860-A1 | HALOVINYL-DERIVATIVES. | HOFFMANN LA ROCHE (CH) | 1993-09-15 | — | — | EP | disclosed |
| WO-1993007234-A1 | HALOVINYL-DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-15 | — | — | WO | disclosed |